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Objectives: Increased caseload has been associated with better patient outcomes in many areas of health care,
including high-risk surgery and cancer treatment. However, such a positive volume vs. outcome relationship has
not yet been validated for cervical cancer brachytherapy. The purpose of this study was to examine the relationship
between physician caseload and survival rates in cervical cancer treated with brachytherapy using population-based
data.
Methods: Between 2005 and 2010, a total of 818 patients were identified using the Taiwan National Health
Insurance Research Database. Multivariate analysis using a Cox proportional hazards model and propensity scores
was used to assess the relationship between 5-year survival rates and physician caseloads.
Results: As the caseload of individual physicians increased, unadjusted 5-year survival rates increased (P = 0.005). Using
a Cox proportional hazard model, patients treated by high-volume physicians had better survival rates (P = 0.03), after
adjusting for comorbidities, hospital type, and treatment modality. When analyzed by propensity score, the adjusted
5-year survival rate differed significantly between patients treated by high/medium-volume physicians vs. patients
treated by low/medium-volume physicians (60% vs. 54%, respectively; P = 0.04).
Conclusions: Provider caseload affected survival rates in cervical cancer patients treated with brachytherapy. Both Cox
proportional hazard model analysis and propensity scores showed association between high/medium volume
physicians and improved survival.Introduction
Cervical cancer remains the most important cause
of cancer death in women from Taiwan with an age-
adjusted incidence of 26.2 per one hundred thousand
women [1,2]. The combination of chemotherapy admin-
istered concurrently with radiotherapy shows survival
benefit in patients with bulky and locally advanced cer-
vical cancer [3]. However, dose is related to both local
control of tumor growth and overall survival. The risk of
tissue toxicity currently limits the external radiation dose
that can be safely delivered [4]. Thus, brachytherapy is
often combined with external beam radiotherapy in* Correspondence: DOC31221@ndmctsgh.edu.tw;
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ing normal tissues.
Brachytherapy is a technically demanding process. The
“practice makes perfect” hypothesis may be valid for
such a procedure, in that increased experience improves
patient outcomes. The association between increased
caseload and improved patient outcomes has been re-
ported for both high-risk surgery and cancer treatment
[1,2]. Positive correlations between improved treatment
outcomes and increased caseload volume have been
documented for nasopharyngeal cancer, breast cancer,
oral cancer, and esophageal cancer [2,5-7]. However, such
a positive volume-outcome relationship has not been
established for cervical cancer brachytherapy. The purpose
of this study was to examine the relationship between
physician caseload and survival rates in cervical cancer pa-
tients treated with brachytherapy, using population-based
data.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Ethics statement
The study protocol was approved by the Buddhist Dalin
Tzu Chi General Hospital Institutional Review Boards.
The institutional review board waived the need for writ-
ten informed consent from the participants because the
data analyzed consisted of anonymous secondary data
released to the public for research.
Patients and study design
Between 2005 to 2010, data from the National Health
Insurance (NHI) Research Database was used in this
study. This data contained all covered medical benefit
claims for over 23 million people in Taiwan (approximately
97 percent of the island’s population). All patients with































Values are given as number (percentage).of Disease, Ninth Revision, Clinical Modification codes
180) were included who received radiotherapy or chemora-
diotherapy between 2005 and 2007. Patients were excluded
who had unclear treatment modalities or incomplete phys-
ician data. Finally, 818 patients, treated by 93 radiation on-
cologists during this 5-year period, were included in our
analysis.
Physicians were further stratified by their total patient
volumes (using the unique physician identifiers in this
database) and by their caseload of cervical cancer pa-
tients. The volume category cutoff points (high, medium,
and low) were determined by sorting the 818 patients
into three groups (1–11 cases = low caseload), 12–40
cases = medium caseload, and ≧41 cases = high caseload),
as previously described [5,8]. The volume category cutoff































Table 2 Physician characteristics (n = 93)
Physician caseload group
Variable Low Medium High P -value
(1–11) (12–40) (41–78)
Total no. of physicians 74 14 5
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have approximately equal numbers of patients. These
cervical cancer patients were then linked to death data
extracted from the records covering the years between
1996 and 2010.Age (years) 0.90
Mean ± SD 42 ± 8 41 ± 6 41 ± 4
Gender 0.71
Male 64(86) 13(92) 4(80)
Female 10(13) 1(7) 1(20)
Caseload <0.001
Mean ± SD 3 ± 2 18 ± 7 55 ± 13
Values are given as number (percentage).
Abbreviation: SD = standard deviation.Measurements
The key dependent variable of interest was the 5-year
survival rate. The key independent variables were the
cervical cancer caseloads (low, medium, or high). Other
physician characteristics included age (≦40, 41–50, ≧51
years) and gender. Patient characteristics included age,
geographic location, treatment modality, severity of
disease, enrollee category (EC), and urbanization. The
disease severity in each patient was assessed using the
modified Charlson comorbidity index score, which has
been widely used, in recent years, for risk adjustment in
administrative claims data sets [9].
This study used EC as a proxy measure of socioeco-
nomic status, which is an important prognostic factor in
cancer patients [10,11]. Patients with cervical cancer
were classified into four subgroups: EC 1 (civil servants,
full-time, or regular paid personnel with a government
affiliation), EC 2 (employees of privately owned institu-
tions), EC 3 (self-employed individuals, other employees,
and members of farmers’ or fishermen’s associations),
EC 4 (veterans, low-income families, and substitute ser-
vice draftees), and other [12]. In Taiwan, government
affiliated workers have stable job occupation and fixed
salary in every month than self-employed. On average,
government affiliated workers’ payroll-related amount
for the health insurance was highest.
The hospitals were categorized by ownership (public,
not-for-profit, or for-profit) and hospital type (medical
center, regional hospital, or district hospital).Statistical analysis
The SAS statistical package (version 9.2; SAS Institute, Inc.,
Cary, N.C.) and SPSS (version 21, SPSS Inc., Chicago, IL,
USA) was used for data analysis. A two-sided P value < 0.05
was used to determine statistical significance.
The cumulative 5-year survival rates and the survival
curves for each group were compared by the log-rank
test. Survival was measured from the time of cervical
cancer diagnosis to the time of death. Cox proportional
regression model and survival analysis using propensity
score stratification were used to compare outcomes between
different groups based on caseload.Figure 1 Cervical cancer survival rates by physician caseload.Cox proportional hazards model
The Cox proportional regression model was used to
evaluate the effect of caseload on survival rate afteradjusting for hospital type, surgeon characteristics, and
patient demographics.
Propensity score
Propensity analysis was used to reduce the effect of selec-
tion bias on our hypothesis, as described by Rosenbaum
and Rubin [13-15]. Propensity score stratification replaced
the many confounding factors that might be present in an
observational study with such a variety of factors. To cal-
culate the propensity score in this study, patient character-
istics were entered into a logistic regression model that
predicted selection for high/medium-volume surgeons.
These patient characteristics included the year in which
the patient was diagnosed, their age, gender, Charlson
comorbidity index score, geographic area of residence,
enrollee category, and treatment modality. The study
population was then divided into five discrete strata based
on propensity score. The effect of caseload assignment on
5-year survival rates was analyzed within each quintile.
Table 3 Cervical cancer survival rate and adjusted hazard
ratios by physician caseload groups and the







Medium (12–40) 0.90 (0.69-1.19) 0.49
High (41–78) 0.69 (0.50-0.97) 0.03
Physician age
≦40 years 1
41-50 years 0.94 (0.72-1.24) 0.70




Non-for-profit 0.95 (0.72-1.25) 0.74
For-profit 0.98 (0.69-1.40) 0.95
Hospital level
Medical center 1
Regional hospital 0.70 (0.71-1.26) 0.70




45-54 years 1.26 (0.82-1.92) 0.28
55-64 years 1.11 (0.70-1.74) 0.64
65-74 years 0.96 (0.62-1.48) 0.85
≧75 years 1.23 (078–1.94) 0.36
Comorbidity index score
0 1
1-3 1.40 (1.07-1.83) 0.01
≧4 2.52 (1.93-3.29) <0.001
Treatment modality
Chemoradiotherapy 1
Radiotherapy 1.23 (1.08-1.40) 0.002
Geographic location
North 1
Central 1.17 (0.85-1.62) 0.32
Southern and Eastern 1.12 (0.81-1.55) 0.47
Enrollee category
Other 1
EC 1-2 0.92 (0.65-1.30) 0.65
EC 3 1.02 (0.74-1.39) 0.88
EC 4 1.09 (0.77-1.54) 0.61
Table 3 Cervical cancer survival rate and adjusted hazard
ratios by physician caseload groups and the




Suburban 0.73 (0.56-0.95) 0.02
Rural 0.66 (0.48-0.91) 0.01
95% CI, 95% confidence interval.
Lee et al. Radiation Oncology 2014, 9:234 Page 4 of 6
http://www.ro-journal.com/content/9/1/234The Mantel-Haenszel odds ratio was calculated in
addition to the Cochran-Mantel-Haenszel χ2 statistic.
Results
A total of 346 out of 818 patients (42%) died after under-
going treatment between 2005 and 2007. A total of 93
radiation oncologists were included in the analysis. The
characteristics of the physicians and patients are summa-
rized in Tables 1 and 2. Patients in the low-volume phys-
ician group were more likely to undergo radiotherapy,
reside in Southern and Eastern Taiwan, and have higher
comorbidity score, than their counterparts in other
groups. There were 74 radiation oncologists (80%) in the
low-volume group, 14 physicians (15%) in the medium-
volume group, and five (5%) physicians in the high-
volume group. The mean age of all physicians was 41 ± 6
years. There was no significant difference among physi-
cians who comprised these three caseload groups with
regards to age (P = 0.90).
Analysis using a Cox proportional hazards model
The 5-year survival rates, by physician caseload group,
are shown in Figure 1. The 5-year survival rates were
48%, 54%, and 64% for low-, medium-, and high-volume
surgeons, respectively (P = 0.005). Table 3 shows the
adjusted hazard ratios (calculated using the Cox pro-
portional hazards regression model) after adjusting for
patient comorbidities, hospital type, and treatment mo-
dality. Physicians’ age and 5-year survival have no associ-
ation (P > 0.05). The hazard ratio for age 41–50, and ≧51
during the 5-year follow-up was 0.94 (P = 0.70) and 0.88-
times (P = 0.56) lower than in ≦40 years respectively.
The positive association between survival and physician
caseload remained statistically significant after multivari-
ate analysis. Patients treated by high-volume physicians
had better survival rates (hazard ratio [HR] = 0.69; 95%
confidence interval [CI], 0.50-0.97; P = 0.03), after
adjusting for other factors.
Analysis using propensity scores
Patients were stratified by propensity score and the ef-
fect of physician caseload on survival was assessed. The
population was stratified into propensity quintiles, as
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caseload groups after stratification. The percentage of
patients treated by low-volume physicians decreased
from the first propensity quintile to the fifth, as pre-
dicted by the propensity model. In each of the five strata,
patients treated by high-volume physicians had a higher
5-year survival rate. While controlling for propensity
score (with fewer patients dying who were treated by
high/medium-volume physicians), the P value equaled
0.04 using Cochran-Mantel-Haenszel statistics. This ana-
lysis demonstrated a significant difference in survival be-
tween patients treated by low vs. high/medium-volume
physicians, (adjusted odds ratio = 0.71, 95% CI, 0.51-0.99).
The adjusted 5-year survival rates for low vs. high/medium-
volume physicians were 54% vs. 60%, respectively (P =
0.04).
In summary, cervical cancer patients treated by higher
volume physicians showed improved survival. The ro-
bustness of this result was demonstrated by two different
multivariate analyses, the Cox proportional regression
model and stratification by propensity score.
Discussion
Improved patient outcomes have been correlated with
higher caseload volumes. However, there is limited data
about the use of brachytherapy in cervical cancer patients.
Although the Royal College of Radiologists has made the
pragmatic decision to maintain sufficient experience and
expertise, they are not backed by any published evidence
[16]. We used a Cox proportional hazards model and pro-
pensity score to evaluate the relative patient benefit of treat-
ment by high/medium-volume physicians vs. low -volume
physicians using cervical cancer brachytherapy. From these
results of both forms of multivariate analyses, we found
that the 5-year survival rates for brachytherapy patients
treated by high/medium -volume physicians were signifi-
cantly better compared to patients treated by low-volume
physicians.Table 4 5-year survival rates of cervical patients according to
volume physiciansa
Propensity score stratum Low-volume physician group
No. % of stratum Survival rate
1 112 68 50
2 84 51 50
3 50 30 42
4 19 11 68
5 15 9 60
Total 280 54
aStratum 1 had the strongest propensity for low-volume physician; Stratum 5, for h
bCochran-Mantel-Haenszel statistics; adjusted odds ratio = 0.71,95% confidence inteThe quality of the risk-adjustment techniques used in
analyzing administrative information is an important issue.
In the first part of this study, a Cox proportional hazard
model was used to compare the effects of high/medium
volume versus low volume on survival rates. We found
that treatment by high/medium-volume physicians was sig-
nificantly associated with a lower adjusted hazard ratio for
death. Patients treated by high-volume physicians were
found to have a 31% lower risk of death after adjusting for
comorbidities and other confounding factors. However,
there were differences in clinical conditions between case-
load groups. In the second part of our series, propensity
score was used to stratify patients into five strata with simi-
lar propensity score in order to reduce the effect of selec-
tion bias on caseload groups [14,15,17]. Patients treated
by high/medium-volume physicians were found to have
a 6% relative improvement in adjusted 5-year survival
rate (P = 0.04) compared to those treated by low-volume
physicians.
Several hypotheses have been proposed regarding the
relationship between caseload volume and outcome. They
suggest that increased caseload may help physicians or
hospital staff improve their ability to perform treatment
procedures, such as planning and manipulation of the
radioactive source to target treatment sites, gauze packing,
dose calculation or computerized planning. Careful ma-
nipulation of the target volume is important for treatment
of cervical cancer with brachytherapy. A team that is com-
fortable with a higher caseload volume may be more adept
at administering radiation dosage which improves loco-
regional control of cancer and reduces the risk of toxicity
to nearby normal organs and tissues.
Although our study revealed some issues that may be
useful for policy makers, further research is necessary
to identify differences in care and treatment strategies
among low-, medium-, and high-volume physicians. In
our study, nearly 33% of patients were treated by only
five high-volume radiation oncologists. The viewpointspropensity score strata; low-volume vs. high/medium-
High/medium-volume physician group
(%) No. % of stratum Survival rate (%) P-value
51 31 52 0.07
80 48 62 0.64
114 69 60 0.41
145 88 59 0.44
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of effective protocols and clinical practice guidelines.
Furthermore, the treatment strategies of high-volume
physicians should be analyzed and adopted, throughout
the country, to improve survival rates.
Our study had several limitations. First, we could not as-
sess the relationship of caseload to stage, tumor size or
local control rate because this information was not avail-
able from the database. Although this limitation may
influence our results, Begg et al., using a SEER-Medicare
linked database, reported that cancer stage and patient age
were independent of caseload volume [18]. Though the
health system in Taiwan is not complete the same as the
one in USA, patient in Taiwan are also free to choose any
physician no matter the disease severity, stage or comor-
bidity. In addition, selective referral bias must also be con-
sidered, i.e., healthier patients or patients with early-stage
disease may tend to be referred to the high-volume physi-
cians. Although healthier patients tend to be wealthier
and they advocate for themselves, the National Health In-
surance covered approximately 97 percent of the island’s
population and the hospitals are dispersion in Taiwan.
The probability for patients’ choice is average. Second, the
database does not contain information regarding tobacco
use, dietary habits, and body mass index, which might be
risk factors for cervical cancer. Taken together, given the
robustness of both the evidence and statistical analyses
used in this study, these limitations are unlikely to have
compromised our results.
In summary, using analyses based on a Cox proportional
hazard model and propensity score, we found an associ-
ation between higher caseload volume and improved sur-
vival in cervical cancer patients treated with brachytherapy
using population-based data. In conclusion, higher provider
caseload affects survival in cervical cancer patients treated
with brachytherapy.
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